Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools ACC

ACC

Programs, trials, and reported response and survival for adenoid cystic carcinoma.

Data as of 11.07.2026

Drugs

ACC pipeline

Methods

How a figure gets onto the Adenoid cystic carcinoma (ACC), recurrent or metastatic pages, and what a blank cell means.

Sources

Each value cites one current source. The order is the registry, then an FDA or DailyMed label, then a peer reviewed paper, then a company release. A later source does not get averaged with an earlier one.

What n/r means

n/r means not reported. The file stores null, and the page prints n/r. Zero is stored only when a source says zero. A missing response rate is not written as zero.

Response and survival

Objective response, overall response, progression-free survival, overall survival, and a hazard ratio are printed in the words and the unit the source used. A percent is drawn as a bar only when the unit is percent. A patient count stays a count. Weeks are not converted into months, and months are not converted into weeks. A hazard ratio is shown only when the source states that ratio. This file does not subtract one arm from another.

Single arm means the source describes one treatment arm, not a randomized comparison. ITT means the source uses intention to treat or treatment regimen. An arm with no named estimand is marked n/r. It is not dropped into another set.

What these pages leave off

Weight curves, responder thresholds, and HbA1c are not on these pages. This file does not report a week by week weight change. A dotted line from zero would invent a path, so it is omitted.

Pipeline dates

A black mark is a readout, including a congress or company data readout. A yellow mark is another company date, such as a planned start or a first dose. A circle is an approval, or an FDA action date the source names, such as a PDUFA goal or a Fast Track grant. The words on the mark are the source’s words. A hollow mark is the registry primary completion date. That date is not stored as a readout. A quarter or a half year is placed on the first month of that span, and the label keeps Q or H. A date before 2025 or after 2030 sits on the near edge of the timeline. The label still shows the date.

Discontinued

“Discontinued” is used when a company or regulator source says the program stopped. “Trials stopped” means every registry record for that program is terminated or withdrawn, and the program is not approved or filed. A completed trial is not treated as a stop.

Comparisons

Arms from different trials sit next to each other so a reader can see dose, population, estimand, and the reported figure. That lineup is not a head to head result. A randomized trial that assigns the treatments in the same study is the strongest comparison. Bars that share a unit are drawn on that unit only.

Stale

A fact is marked stale when its as of date is before November 2026. The number stays. The tag means the monthly review is due. The review reads the source again. It does not invent a fresher number.

Route of administration

Route sits on each drug in an arm. The vocabulary is oral, subcutaneous, intravenous, intramuscular, intrathecal, inhaled, intranasal, transdermal, topical, and other. A missing route is unknown. Injectable checks subcutaneous, intravenous, and intramuscular together. Radiotherapy is a treatment type, not a drug route. A combination stays one row, and each component shows its own route.

Endpoints

Response and survival use a fixed code, with the unit and the assessor kept apart from the population. A placebo figure that the source names as the placebo arm is stored on that arm.

Where this file lives

These pages read seed files. The files are not written into the production database. The preview flag still decides whether the pages are served. Company names link to a profile only when that company already has one on this site. The ticker is stored when a source supports it, and it is not a column on these pages.